Key elements of bioanalytical method validation for small molecules Surendra BansalAnthony DeStefano OriginalPaper Article: 11
Biomarker qualification pilot process at the US Food and Drug Administration Federico GoodsaidFelix Frueh OriginalPaper Article: 10
Nonviral gene delivery: What we know and what is next Xiang GaoKeun-Sik KimDexi Liu OriginalPaper Article: 9
Informatics: The fuel for pharmacometric analysis Thaddeus H. GraselaJill Fiedler-KellyBarry Smith OriginalPaper Article: 8
A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples Robert J. BauerSerge GuzyChee Ng OriginalPaper Article: 7
AAPS-FDA workshop white paper: Microdialysis principles, application, and regulatory perspectives report from the Joint AAPS-FDA Workshop, November 4–5, 2005, Nashville, TN Chandra S. ChaurasiaMarkus MüllerHelen Yeo Report Article: 6
The history of bioanalytical method validation and regulation: Evolution of a guidance document on bioanalytical methods validation Vinod P. Shah OriginalPaper Article: 5
Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays C. T. ViswanathanSurendra BansalRussell Weiner OriginalPaper Article: 4
Dual dopamine/serotonin releasers as potential medications for stimulante and alcohol addictions Richard B. RothmanBruce E. BloughMichael H. Baumann OriginalPaper Article: 1